CyMedica Orthopedics announces FDA clearance for IntelliHab, a novel drug free, non-invasive modality for treatment of knee osteoarthritis pain

CyMedica Orthopedics

9 June 2021 - CyMedica Orthopedics today announced the U.S. FDA has cleared the submission of its latest technology for the management of knee osteoarthritis pain, IntelliHab. 

With this clearance, IntelliHab is the only neuromodulation strengthening therapy indicated to treat pain associated with the debilitating osteoarthritis disease.

Read CyMedica Orthopedics press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , US , Device